Indication intelligence, analysis and sector perception

RegMed/Cell and Gene Therapy Earnings Scorecard Q3/20 LPS Results

November 28, 2020

A scorecard of 34 earnings releases and 1 acquisition of 35 covered companies The current LPS (loss per share) or net income, cash positions i.e. "runways" is a reflection of this universe's investing "status"  

Bellicum Pharmaceuticals (BLCM) closes 1.04 M share offering

November 4, 2020

BLCM priced offering at $6.025 raising $25 million

Q2/20 Earnings - (LPS - loss-per-share) Results

September 15, 2020

A scorecard of 1 restatement and 1 acquisition of 35 covered  companies The current LPS (loss per share) or net income, cash positions i.e. "runways"  is a reflection of this universe's investing "status"